Vasoactive Intestinal Peptide Antagonist, Human ([Ac-Tyr1, D-Phe2l (Growth Hormone Releasing Factor amide 1-29, VIP)

  • Catalog number
    MBS658624
  • Price
    Please ask
  • Size
    1 mg
  • Products_type
    Peptide
  • Products_short_name
    [Vasoactive Intestinal Peptide Antagonist]
  • Other_names
    [vasoactive intestinal polypeptide receptor 1 isoform 1; Vasoactive intestinal polypeptide receptor 1; vasoactive intestinal polypeptide receptor 1; VIP receptor, type I; PACAP type II receptor; VIP and PACAP receptor 1; pituitary adenylate cyclase activating polypeptide receptor, type II; vasoactive intestinal peptide receptor 1; Pituitary adenylate cyclase-activating polypeptide type II receptor; PACAP type II receptor; PACAP-R-2; PACAP-R2; VPAC1]
  • Other_gene_names
    [VIPR1; VIPR1; II; HVR1; RDC1; V1RG; VIPR; VIRG; VAPC1; VPAC1; VPAC1R; VIP-R-1; VPCAP1R; PACAP-R2; PACAP-R-2; VIP-R-1; PACAP type II receptor; PACAP-R-2; PACAP-R2]
  • Reactivity
    Human
  • Purity
    Highly Purified~95%. Purified by HPLC.
  • Form
    Supplied as a lyophilized powder.
  • Storage_stability
    Lyophilized powder may be stored at 4 degree C for short-term only. Stable for 12 months at -20 degree C. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20 degree C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer._x000B_
  • Description
    The antagonist receptor ligand binding will be in contrast with agonist activity. MyBioSource produces more antagonist and receptor related products as 1. Aplha, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation. Complex subunit associated factors are involved in hybridoma growth, Eosinohils, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex. NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells. Hormone releasing factors and releasing hormones are  signaling molecules produced by glands in multicellular organisms. The glands that secrete Luteinizing hormones LHRG and LH, FSH comprise the endocrine signaling system. The term growth hormone releasing hormone GHRH is sometimes extended to include chemicals produced by cells that affect the same cell (autocrine or intracrine signaling) or nearby cells (paracrine signaling). Human recombinant LHRG and GHRH are produced in E. coli or in yeast cells. Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
  • Properties
    Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
  • Gene target
  • Gene symbol
    VIP, SNORD114-29, SNORD115-29, SNORD116-29, IGHV3-29, IGLV3-29, IGKV2-29, ERVK-29, IGKV2D-29, ERVW-29
  • Short name
    Vasoactive Intestinal Peptide Antagonist, ([Ac-Tyr1, D-Phe2l (Growth Hormone Releasing Factor amide 1-29, VIP)
  • Technique
    peptide, peptides
  • Host
    Synthetic peptide
  • Species
    Human, Humans
  • Alternative name
    Vasoactive Intestinal short protein sequence Antagonist, H. sapiens ([Ac-Tyr1, D-Phe2l (Growth Hormone Releasing Factor amide 1-29, VIP)
  • Alternative technique
    peptides
Gene info
Gene info
Gene info
Gene info
Gene info
  • Identity
  • Gene
  • Long gene name
    immunoglobulin heavy variable 3-29 (pseudogene)
  • Synonyms gene name
    • immunoglobulin heavy variable 3-29
    • immunoglobulin heavy variable 3-29 pseudogene
  • GenBank acession
  • Locus
  • Discovery year
    2000-04-04
  • Entrez gene record
  • RefSeq identity
  • Classification
    • Immunoglobulin heavy locus at 14q32.33
  • VEGA ID
Gene info
  • Identity
  • Gene
  • Long gene name
    immunoglobulin lambda variable 3-29 (pseudogene)
  • Synonyms gene name
    • immunoglobulin lambda variable 3-29
  • GenBank acession
  • Locus
  • Discovery year
    2000-05-08
  • Entrez gene record
  • RefSeq identity
  • Classification
    • Immunoglobulin lambda locus at 22q11.2
  • VEGA ID
Gene info
  • Identity
  • Gene
  • Long gene name
    immunoglobulin kappa variable 2-29
  • Synonyms gene name
    • immunoglobulin kappa variable 2-29 (gene/pseudogene)
  • GenBank acession
  • Locus
  • Discovery year
    2000-04-18
  • Entrez gene record
  • RefSeq identity
  • Classification
    • Immunoglobulin kappa locus at 2p11.2
  • VEGA ID
Gene info
  • Identity
  • Gene
  • Long gene name
    endogenous retrovirus group K member 29
  • Synonyms gene name
    • endogenous retrovirus group K, member 29
  • GenBank acession
  • Locus
  • Discovery year
    2014-01-03
  • Pubmed identfication
Gene info
Gene info
  • Identity
  • Gene
  • Long gene name
    endogenous retrovirus group W member 29
  • Synonyms gene name
    • endogenous retrovirus group W, member 29
  • GenBank acession
  • Locus
  • Discovery year
    2013-10-21
Product images
Similar products
Filters
Contact
Chat with gentaur.com employee